Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1962 clinical trials
None
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.

chemoradiotherapy
lung carcinoma
durvalumab
  • 421 views
  • 16 Jan, 2022
  • 137 locations
None
A Study of Sasanlimab With Other Therapies in People With Non-small Cell Lung Cancer

The purpose of this study is to learn if the study medicine (sasanlimab) along with other study medicines is safe and effective in people with non-small cell lung cancer that has spread outside

cancer chemotherapy
measurable disease
lung carcinoma
  • 0 views
  • 19 Jan, 2022
  • 58 locations
None
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Non Small Cell lung cancer (NSCLC) remains the first cause of death by cancer in the World. For the patients presenting a NSCLC stage IV, the median of survival is about 15 months today. The

gilbert's syndrome
liver metastasis
cancer
tumor cells
metastasis
  • 22 views
  • 25 Jan, 2021
  • 46 locations
None
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

The purpose of this study is to improve early detection of treatable relapse of lung cancer and thereby improve survival and quality of life for the patients. The investigators will perform a

adjuvant chemotherapy
lung carcinoma
cancer chemotherapy
ct scan
liquid biopsy
  • 0 views
  • 26 Jan, 2021
  • 3 locations
None
Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer Patients

This is a Phase III, randomized, placebo-controlled, double-blind, multi-center study assessing the efficacy and safety of durvalumab with SoC SBRT versus placebo with SoC SBRT in patients with unresected clinical Stage I/II lymph node-negative (T1 to T3N0M0) NSCLC.

lung carcinoma
stereotactic body radiation therapy
durvalumab
  • 166 views
  • 28 Apr, 2021
  • 227 locations
None
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone

stage iv non-small cell lung cancer
carboplatin
paclitaxel
  • 10 views
  • 07 Nov, 2020
  • 1 location
None
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).

growth factor
stage iv non-small cell lung cancer
EGFR
solid tumour
epidermal growth factor
  • 42 views
  • 09 Jan, 2022
  • 306 locations
None
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

-small cell lung cancer (NSCLC) with documented advanced or metastatic epidermal growth factor receptor (EGFR) mutation (Phase 1b expansion cohorts A, B and C), to estimate the antitumor activity of

platinum-based chemotherapy
afatinib
growth factor
gefitinib
targeted therapy
  • 10 views
  • 12 Jan, 2022
  • 93 locations
None
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

The reason for this study is to see if the study drug, selpercatinib, compared to placebo is effective and safe in delaying cancer return in participants with early-stage non-small cell lung

cancer chemotherapy
kidney function test
lung carcinoma
RET
adjuvant chemotherapy
  • 0 views
  • 16 Jan, 2022
  • 168 locations
None
Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

The purpose of the study is to learn whether the study drug (capmatinib) helps to control lung cancer better compared to a single agent chemotherapy (docetaxel) and whether it is safe when given

growth factor
lung carcinoma
EGFR
systemic therapy
epidermal growth factor
  • 0 views
  • 12 Dec, 2021
  • 54 locations